Evaluation of coronary endothelial function by catheter-type NO sensor in high-fat-diet-induced obese dogs

Circulation Journal

Volumn 73, Issue 3, 2009, Pages 562-567

  Kume, Teruyoshi ^a   Kawamoto, Takahiro ^a   Okura, Hiroyuki ^a   Neishi, Yoji ^a   Hashimoto, Ken ^a   Hayashida, Akihiro ^a   Watanabe, Nozomi ^a   Kanda, Yukiko ^a   Mochizuki, Seiichi ^a   Goto, Masami ^a   Yoshida, Kiyoshi ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Catheters; Coronary circulation; Metabolic syndrome; Nitric oxide; Obesity

Indexed keywords

ACETYLCHOLINE; CHOLESTEROL; GLUCOSE; INSULIN; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW VELOCITY; BODY WEIGHT; CATHETER; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HEMODYNAMICS; INSULIN BLOOD LEVEL; LIPID DIET; MALE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; SENSOR; STATISTICAL ANALYSIS;

ACETYLCHOLINE; ANIMALS; BLOOD GLUCOSE; CORONARY CIRCULATION; CORONARY VESSELS; DIETARY FATS; DOGS; ENDOTHELIUM, VASCULAR; FEMALE; HEART CATHETERIZATION; INSULIN; MALE; NITRIC OXIDE; OBESITY; VASODILATOR AGENTS;

EID: 62649171717     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0789     Document Type: Article

References (49)

1. Tune JD, Gorman MW, Feigl EO. Matching coronary blood fow to myocardial oxygen consumption. J Appl Physiol 2004; 97: 404-415.
2. Prasad A, Zhu J, Halcox JP, Waclawiw MA, Epstein SE, Quyyumi AA. Predisposition to atherosclerosis by infections: Role of endothelial dysfunction. Circulation 2002; 106: 184-190.
3. Mohri M, Egashira K, Tagawa T, Kuga T, Tagawa H, Harasawa Y, et al. Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure. Hypertension 1997; 30: 50-56.
4. Quyyumi AA, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO 3rd. Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia: Comparison of acetylcholine and substance P. Circulation 1997; 95: 104-110.
5. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res 2000; 87: 840-844.
6. Ji Y, Han Y, Diao J, Huang Y, Chen Q, Ferro A. Rabbit aortic endothelial dysfunction by low-density lipoprotein is attenuated by L-arginine, L-ascorbate and pyridoxine. Br J Pharmacol 2003; 140: 1272-1282.
7. Luscher TF, Tanner FC, Tschudi MR, Noll G. Endothelial dysfunction in coronary artery disease. Annu Rev Med 1993; 44: 395-418.
8. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, et al. Prognostic signifcance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104: 191-196.
9. Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996; 334: 150-154.
10. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO 3rd, Panza JA. Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation 1998; 97: 851-856.
11. Quinones MJ, Hernandez-Pampaloni M, Schelbert H, Bulnes-Enriquez I, Jimenez X, Hernandez G, et al. Coronary vasomotor abnormalities in insulin-resistant individuals. Ann Intern Med 2004; 140: 700-708.
12. Lteif AA, Han K, Mather KJ. Obesity, insulin resistance, and the metabolic syndrome: Determinants of endothelial dysfunction in whites and blacks. Circulation 2005; 112: 32-38.
13. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948-954.
14. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-1906.
15. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106: 653-658.
16. Targonski PV, Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Lerman A. Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation 2003; 107: 2805-2809.
17. Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, et al. Nitric oxide activity is defcient in spasm arteries of patients with coronary spastic angina. Circulation 1996; 94: 266-271.
18. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046-1051.
19. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81: 491-497.
20. Bache RJ. Vasodilator reserve: A functional assessment of coronary health. Circulation 1998; 98: 1257-1260.
21. Kinlay S, Libby P, Ganz P. Endothelial function and coronary artery disease. Curr Opin Lipidol 2001; 12: 383-389.
22. Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO 3rd. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation 1995; 92: 320-326.
23. Kuvin JT, Karas RH. Clinical utility of endothelial function testing: Ready for prime time? Circulation 2003; 107: 3243-3247.
24. Neishi Y, Mochizuki S, Miyasaka T, Kawamoto T, Kume T, Sukmawan R, et al. Evaluation of bioavailability of nitric oxide in coronary circulation by direct measurement of plasma nitric oxide concentration. Proc Natl Acad Sci USA 2005; 102: 11456-11461.
25. Goto M, Mochizuki S. Plasma detection of NO by a catheter. Med Biol Eng Comput 2008; 46: 509-516.
26. Ikejima H, Imanishi T, Tsujioka H, Kuroi A, Muragaki Y, Mochizuki S, et al. Effect of pioglitazone on nitroglycerin-induced impairment of nitric oxide bioavailability by a catheter-type nitric oxide sensor. Circ J 2008; 72: 998-1002.
27. Imanishi T, Kuroi A, Ikejima H, Mochizuki S, Goto M, Akasaka T. Evaluation of pharmacological modulation of nitroglycerin-induced impairment of nitric oxide bioavailability by a catheter-type nitric oxide sensor. Circ J 2007; 71: 1473-1479.
28. Hasegawa S, Hasumi S, Katsumori K, Karibe S, Sako T, Iwamoto Y, et al. Alteration of glucose metabolism by long term high fat and high calorie diet in dogs. J Jpn Diab Soc 2001; 44: 197-202.
29. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
30. Makimattila S, Yki-Jarvinen H. Endothelial dysfunction in human diabetes. Curr Diab Rep 2002; 2: 26-36.
31. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334: 952-957.
32. Pyorala M, Miettinen H, Halonen P, Laakso M, Pyorala K. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: The 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 2000; 20: 538-544.
33. Rocchini AP, Marker P, Cervenka T. Time course of insulin resistance associated with feeding dogs a high-fat diet. Am J Physiol 1997; 272: E147-E154.
34. Petrie JR, Ueda S, Webb DJ, Elliott HL, Connell JM. Endothelial nitric oxide production and insulin sensitivity: A physiological link with implications for pathogenesis of cardiovascular disease. Circulation 1996; 93: 1331-1333.
35. Laine H, Yki-Jarvinen H, Kirvela O, Tolvanen T, Raitakari M, Solin O, et al. Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood fow in obesity. J Clin Invest 1998; 101: 1156-1162.
36. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction: Implications for the syndrome of insulin resistance. J Clin Invest 1996; 97: 2601-2610.
37. Balletshofer BM, Rittig K, Enderle MD, Volk A, Maerker E, Jacob S, et al. Endothelial dysfunction is detectable in young normotensive frst-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 2000; 101: 1780-1784.
38. Inoue T, Matsunaga R, Sakai Y, Yaguchi I, Takayanagi K, Morooka S. Insulin resistance affects endothelium-dependent acetylcholineinduced coronary artery response. Eur Heart J 2000; 21: 895-900.
39. Winters B, Mo Z, Brooks-Asplund E, Kim S, Shoukas A, Li D, et al. Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lep(ob)) mice. J Appl Physiol 2000; 89: 2382-2390.
40. Katakam PV, Ujhelyi MR, Hoenig ME, Miller AW. Endothelial dysfunction precedes hypertension in diet-induced insulin resistance. Am J Physiol 1998; 275: R788-R792.
41. Abe H, Yamada N, Kamata K, Kuwaki T, Shimada M, Osuga J, et al. Hypertension, hypertriglyceridemia, and impaired endothelium-depen-dent vascular relaxation in mice lacking insulin receptor substrate-1. J Clin Invest 1998; 101: 1784-1788.
42. Montagnani M, Quon MJ. Insulin action in vascular endothelium: Potential mechanisms linking insulin resistance with hypertension. Diabetes Obes Metab 2000; 2: 285-292.
43. Soucy KG, Ryoo S, Benjo A, Lim HK, Gupta G, Sohi JS, et al. Impaired shear stress-induced nitric oxide production through decreased NOS phosphorylation contributes to age-related vascular stiffness. J Appl Physiol 2006; 101: 1751-1759.
44. Wheatcroft SB, Williams IL, Shah AM, Kearney MT. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med 2003; 20: 255-268.
45. Cardillo C, Nambi SS, Kilcoyne CM, Choucair WK, Katz A, Quon MJ, et al. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 1999; 100: 820-825.
46. Piatti PM, Monti LD, Galli L, Fragasso G, Valsecchi G, Conti M, et al. Relationship between endothelin-1 concentration and metabolic alterations typical of the insulin resistance syndrome. Metabolism 2000; 49: 748-752.
47. Irving RJ, Noon JP, Watt GC, Webb DJ, Walker BR. Activation of the endothelin system in insulin resistance. Q J Med 2001; 94: 321-326.
48. Verma S, Yao L, Stewart DJ, Dumont AS, Anderson TJ, McNeill JH. Endothelin antagonism uncovers insulin-mediated vasorelaxation in vitro and in vivo. Hypertension 2001; 37: 328-333.
49. Morikawa K, Matoba T, Kubota H, Hatanaka M, Fujiki T, Takahashi S, et al. Infuence of diabetes mellitus, hypercholesterolemia, and their combination on EDHF-mediated responses in mice. J Cardiovasc Pharmacol 2005; 45: 485-490. 50. Yada T, Shimokawa H, Hiramatsu O, Haruna Y, Morita Y, Kashihara N, et al. Cardioprotective role of endogenous hydrogen peroxide during ischemia-reperfusion injury in canine coronary microcircula-tion in vivo. Am J Physiol Heart Circ Physiol 2006; 291: H1138 - H1146. 51. Houghton JL, Davison CA, Kuhner PA, Torossov MT, Strogatz DS, Carr AA. Heterogeneous vasomotor responses of coronary conduit and resistance vessels in hypertension. J Am Coll Cardiol 1998; 31: 374-382.